Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls

Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity

(2014) J. Assies et al.   ACTA PSYCHIATRICA SCANDINAVICA

Myelination, oligodendrocytes, and serious mental illness

(2014) V. Haroutunian et al.   GLIA

Possibility of Polyunsaturated Fatty Acids for the Prevention and Treatment of Neuropsychiatric Illnesses

(2014) Michio Hashimoto et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis

(2014) Robert K. McNamara et al.   PSYCHIATRY RESEARCH

A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics

(2014) Marilena Gilca et al.   PSYCHOPHARMACOLOGY

A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia

(2014) Robin Emsley et al.   SCHIZOPHRENIA RESEARCH

Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia

(2014) N J M van Beveren et al.   Translational Psychiatry

Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: Implications for clinical utility

(2013) William S. Harris et al.   Journal of Clinical Lipidology

Relationship between central and peripheral fatty acids in humans

(2013) Jade Guest et al.   Lipids in Health and Disease

Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration

(2013) Carola I.F. Janssen et al.   PROGRESS IN LIPID RESEARCH

Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update

(2013) I. E. Sommer et al.   SCHIZOPHRENIA BULLETIN

Identification of Subgroups of Schizophrenia Patients With Changes in Either Immune or Growth Factor and Hormonal Pathways

(2013) E. Schwarz et al.   SCHIZOPHRENIA BULLETIN

RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients

(2013) Jagadeesh Sridhara Rao et al.   SCHIZOPHRENIA RESEARCH

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: When do they begin to be effective?

(2013) Nilufar Mossaheb et al.   SCHIZOPHRENIA RESEARCH

Early interventions to prevent psychosis: systematic review and meta-analysis

(2013) M. R. Stafford et al.   BMJ-British Medical Journal

A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia

(2013) H Bentsen et al.   Translational Psychiatry

Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods

(2012) Nikie Korver et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

Statistical Methodological Issues in Handling of Fatty Acid Data: Percentage or Concentration, Imputation and Indices

(2012) Roel J. T. Mocking et al.   LIPIDS

Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments

(2012) George Bartzokis   NEUROPHARMACOLOGY

Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia

(2012) Undurti N. Das   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells

(2012) H. Bentsen et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis

(2012) Wendela P. Hoen et al.   PSYCHIATRY RESEARCH

Polyunsaturated Fatty Acid Concentration Predicts Myelin Integrity in Early-Phase Psychosis

(2012) B. D. Peters et al.   SCHIZOPHRENIA BULLETIN

A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia

(2012) W.J.M. van der Kemp et al.   SCHIZOPHRENIA RESEARCH

Bimodal Distribution of Polyunsaturated Fatty Acids in Schizophrenia Suggests Two Endophenotypes of the Disorder

(2011) Håvard Bentsen et al.   BIOLOGICAL PSYCHIATRY

Identification of a biological signature for schizophrenia in serum

(2011) E Schwarz et al.   MOLECULAR PSYCHIATRY

Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory

(2011) George Bartzokis et al.   SCHIZOPHRENIA RESEARCH

Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders

(2010) G. Paul Amminger et al.   ARCHIVES OF GENERAL PSYCHIATRY

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients

(2010) Roosmarijn C. Drexhage et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Rethinking schizophrenia

(2010) Thomas R. Insel   NATURE

Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia

(2010) M.M. Sethom et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia

(2009) George Bartzokis et al.   SCHIZOPHRENIA RESEARCH

Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments

(2008) P. M. Thompson et al.   CEREBRAL CORTEX

Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake

(2008) Leanne Hodson et al.   PROGRESS IN LIPID RESEARCH